BETA: Please send your feedback!
Trade Desk
TTD:NAS
Advertising/Marketing Services
$11.20bn
SMALL cap
$248.79
(-11.10%)
1.19%
since start of 2019
110.84
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Other
Founded 1996
The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on leading acute and intensive care hospitals worldwide. The company markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Paul E. Ross, MBA, CPA | Chief Financial Officer | Male |
| Jeffrey Terry Green | Chief Executive Officer & Director | Male |
| Rob Perdue, MBA | Chief Operating Officer & Director | Male |
| David R. Pickles | Chief Technology Officer | Male |
| Vivian Yang, CPA | Chief Legal Officer | Female |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 2
Medicines - Competitors and Related Companies
How Medicines stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Medicines
MDCO:NAS
Pharmaceuticals: Other
$2.77bn
MID cap
$34.95
(-0.83%)
0.90%
since start of 2019
-11.89
Loading…